We have all missed your entertainment.
While not all 100% true regarding writer the rest is.
AS he's a true Fake-it till you make-it man, but it's another thing to grossly miss-lead loyal shareholders, time after time.
The AS-BS tripped him up when he tangled with the very professional OrbiMed.
They've held him to task with a contract when he BS'ed UNIS could take >$55mil in customer receipts in 2015.
OrbiMed will be the winner...
Hopefully Unilife can harness a JV with someone with deep pockets to see them through till they reap pay-dirt.
There's a lot of sharks out there waiting for those expensive R&D products in the Unilife portfolio.
I hope they don't get them in a fire-sale...
How long is 10MM going to last... With no funding for next year??
RIP T4F
I noticed yr mates over the back fence have disappeared from the CDI Top 20 list this year... Odd?
Who informed them?
Rp.
.
.
UNS Price at posting:
25.0¢ Sentiment: None Disclosure: Held